← Back to Clinical Trials
Recruiting NCT07021404

NCT07021404 The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07021404
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Suicidal Ideation
Study Type OBSERVATIONAL
Enrollment 50,000 participants
Start Date 2006-12-31
Primary Completion 2033-03-31

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Semi-structured interview (Guideline for Suicide care and Evaluation =LOES)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50,000 participants in total. It began in 2006-12-31 with a primary completion date of 2033-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to collect data in Flanders on the incidence of suicide attempts and suicidal ideation across various healthcare settings. The study also aims to assess the proportion of individuals who receive adequate aftercare following a suicide attempt and to systematically document the methods and means used in suicidal behavior.

Eligibility Criteria

Inclusion Criteria: * Everyone who is admitted alive to the emergency department after a suicide attempt is included. All methods used during the suicide attempt are included. Regarding the method of suicide attempts, a distinction is made between self-injury (hanging, strangulation, drowning, stab and cut wounds, jumping from a height, etc.) and self-poisoning (ingestion of (psycho)pharmaceuticals, drugs, alcohol, chemicals, or other harmful substances). * Everyone who is admitted with suicidal thoughts Exclusion Criteria: * Accidental overdose, e.g., someone taking medication for a medical condition without any intent to harm themselves * Alcohol intoxication without any intent to harm oneself * Accidental overdose involving party drugs * Individuals who were deceased upon arrival at the hospital due to suicide

Contact & Investigator

Central Contact

Nikita Vancayseele, Msc

✉ nikita.vancayseele@ugent.be

📞 +32 (0)9 332 07 75

Principal Investigator

Gwendolyn Portzky, Prof

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT07021404 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07021404 currently recruiting?

Yes, NCT07021404 is actively recruiting participants. Contact the research team at nikita.vancayseele@ugent.be for enrollment information.

Where is the NCT07021404 trial being conducted?

This trial is being conducted at Aalst, Belgium, Antwerp, Belgium, Antwerp, Belgium, Bilzen, Belgium and 11 additional locations.

Who is sponsoring the NCT07021404 clinical trial?

NCT07021404 is sponsored by University Hospital, Ghent. The principal investigator is Gwendolyn Portzky, Prof at University Ghent. The trial plans to enroll 50,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology